Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori. 2008

Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
First Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, Japan.

OBJECTIVE To examine the significance of alteration of p53-regulated apoptosis-induced protein 1 (p53AIP1) expression in gastric carcinogenesis in patients with Helicobacter pylori infection. BACKGROUND H. pylori infection induces gastric mucosal inflammation and DNA damage of epithelial cells, which associate with gastric carcinogenesis. p53AIP1 is expressed after DNA damage and induces apoptosis in human cell lines. METHODS Endoscopic antral and corpus biopsies were obtained from 13 patients with chronic gastritis and 17 with gastric cancer. Expression of p53AIP1 and p53DINP1 mRNA was examined by semiquantitative reverse transcription polymerase chain reaction and mutation of p53 codon-46 was studied by direct sequence analysis. The grade of gastritis was assessed according to the updated Sydney System. Results were compared between patients with gastric cancer and chronic gastritis. RESULTS In the antrum, p53AIP1 mRNA expression was significantly lower in patients with gastric cancer than in those with chronic gastritis (P<0.05). In patients with chronic gastritis, expression of p53AIP1 mRNA was significantly higher in the antrum than in the corpus (P<0.05). In patients with chronic gastritis, antral mucosa with high p53AIP1 expression tended to have severe intestinal metaplasia. No mutation was found at p53 codon-46. CONCLUSIONS In H. pylori-infected gastric mucosa expression of p53AIP1 would be higher when the inflammation is severe or intestinal metaplasia is present. Insufficient expression of p53AIP1 may play a role in gastric carcinogenesis in patients infected with H. pylori infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011706 Pyloric Antrum The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS). Antrum, Pyloric,Gastric Antrum,Antrum, Gastric,Antrums, Gastric,Antrums, Pyloric,Gastric Antrums,Pyloric Antrums
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
January 2012, PloS one,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
March 2019, Advances in medical sciences,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
July 1998, British journal of cancer,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
October 1998, Journal of gastroenterology,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
January 2013, Revista de gastroenterologia de Mexico,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
October 1998, Journal of clinical pathology,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
September 2005, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
December 1995, Scandinavian journal of gastroenterology,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
April 1992, Journal of clinical pathology,
Manabu Sawaya, and Tetsuro Yoshimura, and Tadashi Shimoyama, and Akihiro Munakata, and Shinsaku Fukuda
April 2005, World journal of gastroenterology,
Copied contents to your clipboard!